XML 106 R88.htm IDEA: XBRL DOCUMENT
v3.24.0.1

RELATED PARTY TRANSACTIONS - Schedule of related parties (Details) - Related Party - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Related Party Transaction [Line Items] |  |  |
Payments to related party | $ 11,881,000 | $ 6,955,000 | $ 390,000
Scitus Pharma Services |  |  |
Related Party Transaction [Line Items] |  |  |
Payments to related party | 3,646,000 | 2,075,000 | 0
SS Pharma LLC |  |  |
Related Party Transaction [Line Items] |  |  |
Payments to related party | 8,235,000 | 3,669,000 | 0
Esjay Pharma LLC |  |  |
Related Party Transaction [Line Items] |  |  |
Payments to related party | 0 | 101,000 | 25,000
Nuray Chemical Private Limited |  |  |
Related Party Transaction [Line Items] |  |  |
Payments to related party | $ 0 | $ 1,110,000 | $ 365,000

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(c)(2)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(c)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(g)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 + Details
Name: | us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=anip_ScitusPharmaServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=anip_SsPharmaLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=anip_EsjayPharmaLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=anip_NurayChemicalPrivateLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |